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ABSTRACT
We have constructed a novel tetra-promoter vector
(pBVboostFG) system that enables screening of
gene/cDNA libraries for functional genomic studies.
The vector enables an all-in-one strategy for gene
expression in mammalian, bacterial and insect cells
and is also suitable for direct use in vivo. Virus
preparation is based on an improved mini Tn7 trans-
positional system allowing easy and fast production
of recombinant baculoviruses with high diversity
and negligible background. Cloning of the desired
DNAfragmentsorlibrariesisbasedontherecombina-
tion system of bacteriophage lambda. As an example
of the utility of the vector, genes or cDNAs of 18 dif-
ferent proteins were cloned into pBVboostFG and
expressed in different hosts. As a proof-of-principle
of using the vector for library screening, a chromo-
phoric Thr
65-Tyr-Gly
67-stretch of enhanced green
fluorescent protein was destroyed and subsequently
restoredbynovelPCRstrategyandlibraryscreening.
The pBVboostFG enables screening of genome-wide
libraries, thus making it an efficient new platform
technology for functional genomics.
INTRODUCTION
Currently, genomes of over 200 organisms have been sequ-
enced and the work for a number of other species is in pro-
gress (http://www.tigr.org, http://www.genomesonline.org/).
The Human Genome Project, in particular, is revolutionizing
medicine and related biological sciences. Until recently, the
focus in genome projects has been on the identiﬁcation and
sequencingofgenes.Thebaresequenceinformation,however,
is not enough to completely deﬁne the functions of the tens of
thousands of proteins encoded by the revealed open reading
frames. This problem has created a new area in molecular bio-
logy and genetics called functional genomics, which addresses
the functions of genes and gene products at the level of whole
organisms (1).
Conventionally, the most widely used approaches to link a
gene with a function are mutation analysis and production of
knock-outortransgenic animals. These are, however,slowand
costly approaches at the genome scale. DNA (2) and protein
(3) microarrays and proteomics (4) are evolving techniques
used in functional genomics, although these techniques suffer
from their inefﬁciency to detect weakly expressed gene pro-
ducts. Thus, a technology is needed that directly associates the
whole genome libraries, such as arrays of isolated cloned
cDNAs (5), with the possibility of high-throughput screening
for phenotypic changes.
Viral vector systems, in which genes are cloned under
strong promoters, have been explored as one solution to
these problems. Arrayed libraries of thousands of genes can
be constructed within suitable viral vectors, from which gene
functions can be identiﬁed via cell-based assays using high-
throughput screening technology (6,7). Considerable time and
several cloning steps, however, are usually required for the
construction of adenoviral and retroviral expression cassettes
and libraries. In addition, cytotoxicity associated with aden-
oviruses and alphaviruses may affect the obtained results (7).
To address these issues we have developed a new vector
system (pBVboostFG) for library construction which enables
expression and screening of libraries in bacterial, insect
and mammalian cells. The cloning of the libraries into the
pBVboostFG vector is based on the efﬁcient site-speciﬁc
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doi:10.1093/nar/gni042recombination system of bacteriophage lambda (8). The
delivery of the cloned genes can also be done directly
in vivo without any further subcloning steps via baculovirus-
mediated transduction (9). In contrast to adenovirus and
retrovirus systems, the beneﬁts obtained by using the bacu-
lovirus are that at least 50 kb fragments of the DNA can be
incorporated into its genome (10) and no cytotoxity is asso-
ciated with baculoviral vectors in vertebrate cells (11). More-
over, the production of baculoviral libraries by pBVboostFG
system is fast, compatible with high-throughput technology,
and produces a high diversity of clones ( 107 c.f.u./mg) in a
single step without background (12). Here, we describe the
construction of pBVboostFG system and show examples of its
usefulness in areas relevant to functional genomics.
MATERIALS AND METHODS
Vector construction
In order to allow recombinational cloning we ﬁrst inserted the
recombinationcassette ofbacteriophagelambda (8)(Gateway,
Invitrogen) into a vector backbone that contained promoters
functionalinbacteria,insectandmammaliancells.Theexpres-
sion cassette was constructed so that as a rule, the ﬁrst avail-
able ATG codon starts translation. Therefore, all that is
required is to clone an open reading frame or a suitable library
according to bacteriophage lambda’s cloning scheme (8).
The constructed cassette was cloned into the pBVboost vector
(12) and the resultant vector was named as pBVboostFG
(Figure 1A). In practice, a linker sequence was ﬁrst cloned
into an NcoI/BamHI digested pTriEx-1.1 vector (EMD Bio-
sciences). The linker was constructed by annealing the follow-
ing oligonucleotides: F526 (50-GATCGATATCGGATC-30)
andF527(50-CACGGATCCGATATC).Theunderlinedoligo-
nucleotides correspond to the EcoRV site. This linker was also
designed to omit the inherent start codon (ATG) of NcoI in
order to allow the precise initiation of the protein translation of
desired inserts after the recombinational cloning. The resultant
plasmid was named as pBVboostFGpre1 and the blunt-end
gateway cassette Awas cloned intothe introducedEcoRV site.
This vector was named as pBVboostFGpre2. A second linker
preparedbyannealingFgL350 (50-CCTAGGCATGCCCGG-30)
and FgL330 (50-GCATGCCTAGGCCGG-30) oligonucleotides
was then cloned into the FseI cut pBVboostFGpre2. The
underlining indicates SphI sites in the oligonucleotides.
The resultant vector was named as pBVboostFGpreOB.
The pBVboostFGpreOB was then digested with SphI and
the recombinational cloning cassette under the triple promoter
was ligated into a similarly treated pBVboost vector (12). The
resultant vector was named as pBVboostFG (Figure 1A).
Red ﬂuorescent protein was cloned under the polyhedron
promoter (pPolh) by subcloning a SacI and XbaI insert from
pDsRed2-N1 vector (Clonetech) into a SpeI and SacI cut
pBVboostFG.
ThechimericconstructcontainingthebacterialompAsecre-
tion signal fused to avidin cDNA (13) ﬂanked with attL1 (50)
and attL2 (30) sites (8) was obtained using SES-PCR (14)
(Figure 1). Brieﬂy: in SES-PCR (stepwise elongation of
sequence) the ampliﬁed insert was elongated (60–70 nt)
from its 50 end using primers that had desired extra sequences
in their 50 end. The procedure was repeated stepwise in order
to achieve longer constructs (see Figure 1). The avidin SES-
PCR product after three cycles was cloned into pBVboostFG.
The enhanced green ﬂuorescent protein (EGFP)-construct
was prepared similarly and cloned into pBVboostFG and
pBVboostFGR. Other constructs were created in a similar
manner. However, those constructs that contained N-terminal
His-tagwereclonedbyaddingthetagintotheoligonucleotides
that contained gene-speciﬁc sequences and attB sites and the
fragments wereclonedby subsequent BP andLR reactions (8).
The used constructs are summarized in Table 1.
Expression of test genes in bacterial, insect
and mammalian cells
Bacterial expressions were carried out in Escherichia coli
BL21. For the expression of ompA–avidin protein, the produc-
tion was switched on by adding IPTG (1 mM). After overnight
incubation, the cells were fractionated into total, periplasmic
and insoluble fractions, subjected to SDS–PAGE and trans-
ferred onto nylon beat ﬁlters. The proteins were detected using
polyclonal rabbit anti-avidin (15), while goat anti-rabbit
IgG-AP was used as a secondary antibody. EGFP expression
was carried out by growing the bacteria on Luria–Bertani
plates containing IPTG (1 mM) and gentamycin (7 ug/ml),
and EGFP-expressing colonies were detected directly under
UV light.
Recombinant baculoviruses were prepared using the
vectors pBVboostFG + EGFP, pBVboostFGR + EGFP and
pBVboostFG + ProtX (Table 1) as described previously
(12). Sf9 cells (1 · 10
6 in 1 ml) were infected with corres-
ponding baculoviruses for 3 days. For the puriﬁcation of
His-tagged proteins, large-scale infections (200–500 ml)
were performed and the His-tagged proteins were puriﬁed
from the culture medium with Talon
TM resin (BD Bios-
ciences). The glycosylation pattern of the puriﬁed VEGF-A
was studied with Endo Hf glycosidase and western blotting as
described previously (15). The SEAP activity was measured
by chemiluminescent assay according to the manufacturer’s
instructions (BD Great EscAPe
TM, NJ) and by dot plotting.
To test the constructed expression vector in mammalian
cells, human hepatocarcinoma (HepG2) cells and chinese
hamster ovary (CHO) cells were used for the expression of
EGFP driven by the CAG promoter. The functionality of
the vector was tested both by baculoviral transduction
and by plasmid transfection (FuGENE
TM 6, Roche) using
pBVboostFG + EGFP. About 150 000 cells were plated on
6-well plates and after 24 h the cells were either transfected
with 1–2 mg of plasmid DNA or transduced by the virus with
MOI (multiplicity of infection) 300. The cells were incubated
for 24 h and viewed under a ﬂuorescence microscope. For
BVboostFG + VEGF-A and BVboostFG + VEGF-D
DNDC
virus treatments BT4C cells were plated on 6-well plates
(Nunclon
TM, Science kit & Boreal Laboratories, Tonawanda,
NY) at a density of 150000 cells per well. After 24 h of cul-
tivation,viruseswereaddedtothecells(MOI1000)andincub-
atedfor2hat37 C.SamplesforVEGFELISAanalyses(R&D
Systems, Minneapolis, MN) were taken after 24 h of culturing.
In vivo injection of baculovirus into rat brain
Eight female Wistar rats (200–250 g) were injected as
described by Lehtolainen et al. (16) using 2 · 108 p.f.u. of
e42 Nucleic Acids Research, 2005, Vol. 33, No. 4 PAGE 2 OF 10Figure1.MapofthepBVBoostFGvector(A),SES-PCRstrategytoconstructavidinandEGFPcassettesforcloningintopBVboostFG(BandC)andtheprincipleof
theconstructionofthechromophorelibrary(DandE).(A)SacB#3,amutantformofthelevansucrasegene(12);GENT,gentamycinresistancegene;Tn7R/L,leftand
right ends of bacterial transposon TnT7; pPohl, polyhedrin promoter; CAG, chicken b-actin promoter; T7, bacteriophage T7 promoter;. p10, p10 promoter; pA,
transcriptional terminator area. (B) and (C) The dashed lines show the attL sites compatible with LR reaction of the recombinational cloning system and bacterial
ompAsignal(inavidin).(D)ThefirstPCRreactiontoconstructtheEGFPchromophorelibrary:theproductamplifiedin(C)wasusedasatemplateandamplification
wasperformedwithprimers50UNIVandEGFP1.3.(E)ThesecondPCRreactionforlibraryconstruction,usingthesametemplateasinthefirstreaction.Theproduct
of the first reaction was used as a megaprimer and 30UNIV was used as a second primer. The product of this reaction was LR-cloned into pBVboostFG.
(F) Oligonucleotides to synthesize avidin and EGFP constructs and EGFP chromophore library compatible with LR reaction. The attL sequences are shown in
italics and a sequence encoding the ompA signal peptide is underlined.
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The brains were removed and snap-frozen in liquid nitrogen
for cryo-sectioning. These sections were visualized by ﬂuore-
scence microscopy. Frozen sections were ﬁxed in acetone
for immunostaining. Samples were detected with anti-GFP
(Biogenesis) as a primary antibody and with an AP conjugated
anti-sheep (Bethyl Laboratories Inc.) as a secondary antibody
followed by staining using AP substrate (Vector Alkaline
Phosphatase Substrate Kit III, Vector Labs). Tissue samples
were counterstained in Mayer’s Carmalum and observed by
microscope.
Screening of EGFP chromophore library
For the construction of the chromophore library the EGFP
reading frame from pBVboostFG + EGFP was ampliﬁed
using SES-PCR. This product was used for the construction
of the chromophore library using a megaprimer method (17).
The megaprimer was prepared by using primers 50UNIV and
EGFP1.3, of which the latter contains a random nucleotide
mixture in the region that encodes the chromophore [amino
acids 65–67 (18)]. In the second PCR reaction, this product
was used as the megaprimer and the second primer was
30UNIV (Figure 1D and E). The PCR product was then
LR-cloned into pBVboostFG. The reaction end product con-
tained the constructed chromophore library, which was trans-
formed into BL21-AI
TM (Invitrogen) E.coli that were plated
onto LB plates containing gentamycin (7 ug/ml) and arabinose
(0.2% w/v). After overnight incubation the ﬂuorescent colon-
ies were screened under UV illumination, transferred to LB
medium and induced with L-arabinose (0.2% w/v). Following
overnight cultivation, the cells (25 C) were collected by cen-
trifugation (5000 g, 10 min) and suspended into 0.15 mg/ml
lysozyme, 0.5 M glucose, 1 mM EDTA and 200 mM Tris
(pH 7.4), and incubated for 30 min at room temperature
and freeze-thawed. The lysates were supplemented with
50 mM NaPO4 and 150 mM NaCl, pH 7.0, and the insoluble
fraction was pelleted. Fluorescent excitation and emission
spectra were measured from the soluble fraction with
a spectroﬂuorometer (PerkinElmer LS 55 Luminescence
Spectrometer) and the obtained spectra were normalized
according to the ﬂuorescence maximum. A sample from one
non-ﬂuorescent clone was prepared identically to obtain a
negative control. The identiﬁed ﬂuorescent clones and several
non-ﬂuorescent clones were then sequenced using Li-cor
4200S-2 DNA Sequencer. Fluorescent viruses of the identiﬁed
clones were produced and tested in SF9 cells.
RESULTS
Construction of a multipurpose vector compatible with
library screening and gene expression in mammalian,
insect and bacterial cells
In order to construct a single vector that allows expression
of cloned genes or cDNA libraries in different host systems
without any further subcloning, we combined four different
promoters into the same vector. This tetra-promoter cassette
is composed of CAG (CMVie enhancer + chicken b-actin
promoter), T7lac, pPolh and p10, all of which direct efﬁcient
expression of genes in vertebrate cells, E.coli, and
baculovirus-infected insect cells, respectively (Figure 1A).
The multiple cloning site following the pPolh promoter allows
an option to modify the properties of the baculoviruses or to
express a marker gene to detect the synthesis of recombinant
baculoviruses, as exempliﬁed here with red ﬂuorescent pro-
tein. To allow the efﬁcient cloning of the desired libraries (or
genes/cDNAs) into the vector, a site-speciﬁc recombination
cassette of the bacteriophage lambda containing attR1/2 sites
(8) was included into the vector. To further enable fast and
high-throughput production of the recombinant baculoviruses,
we cloned the tetra-promoter cassette as part of the pBVboost
vector that enables zero background generation of recombin-
ant baculovirus genomes with high diversity ( 10
7 c.f.u./mg)
(12), making the vector optimal for library screening. The
resulting vector was designated as pBVboostFG. The cloning
strategy of test genes into pBVboostFG is shown in Figure 1.
For easy detection of the produced recombinant baculoviruses,
red ﬂuorescent protein was cloned into the multiple cloning
site under the pPolh promoter. The vectors used in this study
are summarized in Table 1.
Expression of genes in multiple hosts
To test the functionality of the tetra-promoter in different
expression hosts, we cloned EGFP into pBVboostFG. E.coli
was transformed with this plasmid and the efﬁcient production
of EGFP was easily detected from bacterial cultures growing
on LB plates (Figure 2A). Baculoviruses derived from the
same plasmid were used to infect Sf9 cells. After 3 days
infection the cells were studied using a ﬂuorescence micro-
scope and almost all cells showed bright green ﬂuorescence
(Figure 2B and C). Simultaneous function of both baculoviral
promoters in the Sf9 cells was shown by infecting Sf9 cells
with the virus construct containing red ﬂuorescent protein
under pPohl and EGFP under P10 promoters (Figure 2E–G).
The BVboostFG + EGFP baculovirus was used to transduce
HepG2 (Figure 2H and I) and CHO cells in order to show that
the tetra-promoter construct is also active in mammalian cells.
Green ﬂuorescence was also detected in the plasmid trans-
fected CHO cells (data not shown).
The broad feasibility of the pBVboostFG vector was also
demonstrated by producing several different proteins in dif-
ferent host cells (Figures 2 and 3) (Table 2). The bacterial
Table 1. Description of the vectors used in this study
Vector Description
pBVboost Parent vector for other constructs,
allows high-throughput production of
recombinant baculoviruses (12)
pBVboostFG A derivative of the pBVboost, compatible
with recombinational cloning and
universal expression
pBVboostFGR A derivative of the pBVboostFG, contains
additional marker gene DsRed that
is functional in insect cells
pBVboostFG + ProtX
a A derivative of the pBVboostFG for
the expression of desired proteins
pBVboostFGR + EGFP A derivative of the pBVboostFGR
for the expression of EGFP
aProtX represents different proteins cloned into pBVboostFG in the present
study.
e42 Nucleic Acids Research, 2005, Vol. 33, No. 4 PAGE 4 OF 10ompA secretion signal was fused to the avidin gene in order to
transport the synthesized avidin into the periplasmic space of
E.coli (Figure 1B). The periplasmic expression of avidin was
efﬁcient in E.coli and a remarkable proportion of the total
cellular protein was composed of avidin after overnight induc-
tion. Some of the avidin was produced as insoluble inclusion
bodies (Figure 3A) and the inclusion bodies, as well as the
total cell sample, also contained a non-processed form of the
Figure2.ExpressionofEGFPindifferenthostcells.(A)EGFPexpressioninbacteria:thecultureforminganalphabetAcontainsanavidincassette(negativecontrol
inthisexperiment)whereasEdenotestheculturethatexpressesEGFP.TheplatewasilluminatedunderUVlight.(B)Sf9cellsinfectedwithpBVboostFG+EGFP-
derivedbaculovirus, three daysafter infection,in normallight. (C) Green fluorescencefrom the same cells detectedusingfluorescence microscopy. (D) Anegative
control(non-infectedcells;left,phasecontrast;right,fluorescentimage).In(E–G)Sf9cellsinfectedwithpBVboostFGR+EGFPderivedbaculovirus.(E)Cellswere
studied by detecting green fluorescence whereas in (F) the red fluorescence was detected. (G) The merged image of (E and F). (H and I) HepG2 cells 24 h after
transduction by pBVboostFG+EGFP derived baculovirus. (H) Cells viewed using phase contrast microscopy and (I) the same cells detected by the emitted green
fluorescence. No virus was used for the negative control (J). The magnification of the cells is 20-fold.
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contrast, the ompA signal was cleaved off from virtually all
periplasmic avidins. The biological activity of the periplasmic
avidin was shown by its binding to biotinylated agarose (data
not shown). The puriﬁed VEGF-A produced in the insect
cells contained N-linked glycomoieties typical for wild-type
VEGF-A (Figure 3B).
A collection of proteins expressed in different host cells are
shown in Table 2. The yields of produced proteins varied
between different proteins and hosts. Protein yields were typ-
ically in the range of 3–20 mg/l from E.coli periplasm and
several mg/l from insect cell cultures. Some proteins, such
as SEAP, were expressed in very high concentrations in
insect cells (Figure 3C). High purity after a single afﬁnity-
chromatography step was typically achieved using immobil-
ized metal afﬁnity chromatography or biotin/2-iminobiotin
chromatography. As an example no contaminating bands were
detected in sKDR(1–7), VEGF-D
DNDC (Figure 3D and E) and
several avidin preparations (data not shown). HIV-integrase
shows the strength and ﬂexibility of our system: its production
was strong in E.coli but the protein was mostly degraded
(Figure 3F). Instead, infection of insect cells led to the
production of intact protein (Figure 3G), which showed nor-
mal biological activity in in vitro tests (data not shown) after
afﬁnity chromatography. The VEGF-A and VEGF-D
DNDC
expression in mammalian cells was comparable with that
achieved with adenoviruses containing similar expression
cassettes under the CMV promoter (19): at the 24 h time
point, expression yields for VEGF-A and VEGF-D
DNDC
were 441 and 1094 pg/ml, respectively with the pBVboostFG
vector. Correspondingly, 861 pg/ml (VEGF-A) and 982 pg/ml
(VEGF-DDNDC) were produced by the adenovirus.
EGFP expression in rat brain
To verify the function of the vector system in vivo, EGFP
expressing baculovirus was injected into the rat right lateral
ventricle. Choroid plexus epithelial cells were shown to be
transduced with high efﬁciency as reported previously by
Lehtolainen et al. (16). Strong EGFP production was detected
in choroid plexus cells as seen by anti-GFP immunostaining
and ﬂuorescence microscopy (Figure 4).
Screening of the chromophore library
The synthesized chromophore library was screened as
described in Materials and Methods. Because three consecut-
ive amino acid residues were randomized, the theoretical
diversity of the library was 9261 (21
3, twenty different
amino acids + termination) at the amino acid level and
262144 (4
9) at the nucleic acid level. Out of 20000 screened
colonies, three colonies showed ﬂuorescence under UV light.
These clones were ampliﬁed and sequenced (Table 3), and
their chromophore sequences were found to be SYG, LYG
and THG instead of the TYG in the wild-type EGFP. In order
to verify the diversity of the constructed library, eight non-
ﬂuorescent colonies were also sequenced and they all had
different sequences when compared to wild-type EGFP and
to each other (Table 3). Some non-ﬂuorescent clones were also
induced to express the non-functional EGFP and the produced
protein was recognized on western blot by the EGFP antibody,
which conﬁrmed that products with the correct size were
synthesized (data not shown).
The excitation and emission spectra of the ﬂuorescent
clones were measured to study their spectroscopic properties
(Table 3) (Figure 5). The EGFP-mutant SYG resembles the
wild-type GFP in its spectral properties (l
ex
max = 395–397 nm,
l
em
max = 504 nm). The slight change towards red in the emission
maximum of this variant could be due to the F64L change
in the EGFP-template as compared with the wild-type GFP.
The LYG variant shows spectral properties close to EGFP.
The THG variant shows spectral properties similar to those
reported for blue ﬂuorescent protein.
DISCUSSION
The post-genomic era requires tools to translate the enormous
nucleotidesequencedataintobiologicallyrelevantknowledge,
thus, there is a clear need for versatile vector systems like the
pBVboostFG, developed in this study (5,20,21). One of the
main beneﬁts of these kinds of vectors is their suitability for
many alternative host systems: the library or the single gene/
cDNA can be expressed in E.coli, insect cells and mammalian
Figure 3. Analyses of the proteins expressed by the BVboostFG system.
(A) Western blot of the expressed avidin detected with an avidin antibody.
M, molecular weight markers; control avidin marked with an arrow. T, sample
of total E.coli proteins; P, periplasmic fraction; I, insoluble fraction. The upper
faint band represents ompA secretion signal-containing avidin whereas
the lower band represents the fully processed avidin. Control avidin has a
higher molecular weight because it contains a carbohydrate side chain (38).
(B) Deglycosylation analysis of purified VEGF-A produced in insect cells.
N indicates a sample not treated with endo Hf and T indicates a sample degly-
cosylatedwiththeenzyme.(C)Adot-blotanalysisofSEAPsecretedintoinsect
cell medium.The uppermost dotis 200 ml of mediumdiluted1:10,whereas the
middle dot is a positive control containing 300 ng of SEAP. The lowest dot is a
negative control. (D) and (E) show purified sKDR(1–7) (silver staining) and
VEGF-D
DNDC (Coomassie staining) proteins in SDS–PAGE gel, respectively.
Theproteinswerepurifiedtomilligramamountswithnoapparentcontaminants
which indicate high purity. The lower bands seen in VEGF-D
DNDC preparation
aredifferentglycosylationformsoftheprotein.(F)and(G)showimmunoblots
of HIV-integrase produced in E.coli and insect cells, respectively. Most of the
protein produced in bacteria was degraded whereas protein produced in insect
cells was intact. Proteins were detected with an integrase-specific antibody.
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screen libraries in these hosts but also to utilize the best char-
acteristics of each speciﬁc host for individual purposes as
shown in the current study. E.coli is the most widely utilized
prokaryotic expression system, which provides a cost-efﬁcient
alternative to produce proteins in large quantities. Protein
production in E.coli, however, often leads to poor expression
yields and insoluble end products. Insect cells are able to carry
Table 2. Proteins expressed with pBVboostFG system in different host cells
Protein Description and reference Added tag Used host Analyses
EGFP Enhanced green fluorescent protein
and its screened mutants
— E.coli/ insect/
mammalian
Fluorescent images,
spectral analyses, western blots
DsRed Fast maturation variant of Discosoma sp.
Red fluorescent protein
— Insect Fluorescent images
VEGF-A165 Vascular endothelial growth factor A,
165 amino acid long form (39)
C-terminal 6-His Insect/mammalian Purified by affinity
chromatography/ELISA
VEGF-B186 Vascular endothelial growth factor B,
186 amino acid long form (39)
C-terminal 6-His Insect Purified by affinity
chromatography
VEGF-D
DNDC Vascular endothelial growth factor D,
N and C terminally truncated form (39)
C-terminal 6-His,
N-terminal Flag taq
Insect/mammalian Purified by affinity
chromatography/ELISA
sKDR(1–7) Soluble form of vascular endothelial
growth factor receptor 2,
includes IgG like domains 1-7 (39)
C-terminal 6-His Insect Purified by affinity chromatography
sKDR(1–4) Soluble form of vascular endothelial
growth factor receptor 2,
includes IgG like domains 1-4 (39)
C-terminal 6-His Insect Purified by affinity chromatography
Flt1(1–5) Soluble form of vascular endothelial
growth factor receptor 1,
includes IgG like domains 1-5 (39)
C-terminal 6-His Insect Purified by affinity chromatography
Flt1(1–3) Soluble form of vascular endothelial
growth factor receptor 1,
includes IgG like domains 1-3 (39)
C-terminal 6-His Insect Protein detected with His-tag
antibody
Avidin (13,40) — E.coli Purified by affinity chromatography
AVR2 Avidin related protein 2 (15) — E.coli Purified by affinity chromatography
AVR4/5 Avidin related protein 4/5 (15) — E.coli Purified by affinity chromatography
DcAvd Engineered dual chain form of
chicken avidin (41)
— E.coli Purified by affinity chromatography
LDAvdN54A Modified monoavidin (42) — E.coli Purified by affinity chromatography
Streptavidin Avidin analogue from Streptomyces avidiini
bacteria (43)
— E.coli Protein detected by immunoblotting
HCL-1 Hypothetical calycin like protein from
Bradyrhizobium japonicum (45)
— E.coli Purified by affinity chromatography
HIV integrase (44) N-terminal 6-His E.coli/insect Purified by affinity chromatography
SEAP Secreted alkaline phosphatase,
GenBank accession no. U89937
— Insect Dot-blot and chemiluminescence
analyses
Figure 4. Baculovirus-mediated EGFP (pBVboostFG + EGFP) gene transfer in rat brain. (A) Rat brain choroid plexus cells show  100 % transduction efficiency
(immunostaining,originalmagnification4·).In(B),theareaboxedin(A)isshownat20·magnification,insertshowsfluorescentimageofthechoroidplexuscells
transduced with the virus. Asterisks indicate choroid plexus cells. (C) A negative control from a non-transduced rat at the same magnification as in (B).
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ryotic proteins that may be required for the full activity of
the produced protein (24). Indeed, the baculovirus expression
system has become a widely used eukaryotic protein-
expression system. Some complex proteins may need to be
produced in mammalian cells that have the unique ability to
produce properly processed and biologically active molecules
at reasonable level. Ideally, a protein should be expressed in a
host as near to its origin as possible. The pBVboostFG system
therefore provides a straightforward tool to address this issue.
In general, good expression rates were achieved using the
pBVboostFG tetra-promoter vector in different hosts. This
suggests that the tetra-promoter design allows protein produc-
tion with an efﬁcacy comparable with single promoter vectors.
The universal expression compatibility does not, however,
necessarily guarantee efﬁcient production of all proteins in
all hosts. For example VEGF-D
DNDC and sKDR(1–7) were
not produced successfully in E.coli. This is most likely due
to the fact that the signal peptides of these eukaryotic proteins
are not recognized by the bacterial secretion machinery (25).
Correspondingly, to produce chicken avidin efﬁciently in
E.coli, a bacterial signal sequence was utilized. Another
well-recognized issue relevantto the universal expression con-
cept is codon usage. In highly expressed genes, a narrow set of
species-speciﬁc codons is used, which correspond to the more
abundant tRNA species (26). However, this does not change
the fact that the tetra-promoter concept allows rapid and
straightforward screening through the different hosts and,
depending on the most preferential host, known sequence
constraints can be taken into account in cloning design.
The construction of baculovirus libraries with the
pBVboostFG based system can be accomplished in as little
as one week (12). Easy baculovirus generation and ampliﬁca-
tion provides a rapid transition from in vitro library screening
to animal testing without any further subcloning steps and
therefore, it markedly facilitates the screening of disease-
related genes (11). In this context it is important to note
that baculoviruses can deliver genes into diverse types of
cells from different species (27,28). Viral replication is restric-
ted to speciﬁc insect hosts and the baculovirus genome is silent
in non-permissive cells (27). Further beneﬁt of baculoviruses
is their low cytotoxity (11). An additional advantage of using
baculovirus is that it should be possible to screen also large
DNA inserts (10,29). In contrast, adenoviral and retroviral
gene transfer vectors can incorporate <8 kb of foreign DNA
into their genomes.
The pBVboostFG system offers several advantages as
compared with previously described multiple promoter vec-
tors (22,23). First, the novel tetra-promoter construct allows
dual-gene expression in insect cells. Two insect-cell-speciﬁc
promoters were cloned into pBVboostFG as separate expres-
sion cassettes. This allows preparation of pseudotyped bacu-
loviruses for enhanced gene delivery into vertebrate cells and
animals (30–33) or visualization of virus infection (titering),
which eases and speeds up virus preparation as shown in
the current study. Second, because recombinant baculovirus
Table 3. Sequences of the chromophore-encoding region of three positive
clones found in the screening of the EGFP chromophore library and their
fluorescence properties
Clone DNA-sequence Amino acid
sequence
Fluorescence properties
l
ex
max (nm) l
em
max (nm)
EGFP
a ACCTACGGC TYG 489 509
F1 AGCTACGGA SYG 395(475)
b 508
F2 CTATATGGC LYG 478 506
F5 ACTCACGGC THG 380 447
NF1
c CGCGCATTG RAL
NF2 GGACAACAC GQH
NF3 GGAACACGC GTR
NF4 AATATTCCG NIP
NF5 CTACCAACA LPT
NF6 CAGAAGAAC QKN
NF7 GCAAAGATA AKI
NF8 AAAAAAAGC KKS
The sequences of the eight non-fluorescent clones are also shown.
awild-type EGFP sequence.
bsecondary peak in excitation spectrum.
cnon-fluorescent clone that was used for library construction to eliminate
wild-type fluorescent background.
Figure 5. The excitation and emission spectra (black) of the three fluorescent
proteinmutantsidentifiedbylibraryscreening.Theuppermostspectraarefrom
the SYG variant, the middle spectra from the LYG variant and the lowest
spectra from the THG variant. The measured spectra of the wild-type EGFP
are shown for comparison (grey).
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out time-consuming plaque puriﬁcations to isolate separate
clones. This will accelerate the screening and generation
of recombinant viruses. Third, recombinant bacmids can be
generated at high frequency ( 10
7 c.f.u./mg) virtually free of
background (12), which yields high virus diversity more efﬁ-
ciently than traditional homologous recombination methods
(34) or methods based on conventional restriction enzyme
cloning (35). Fourth, because no restriction enzyme digestions
are required for cloning, the yield of full-length clones is
improved since the inserts will not be cut from internal restric-
tion sites. The use of the bacteriophage lambda recombination
system also provides better cloning efﬁciency than restriction–
ligation based strategies (36). Furthermore, the site-speciﬁc
recombination system of bacteriophage lambda is reversible,
in contrast to many other corresponding site-speciﬁc recom-
binase systems. This feature ensures that, if desired, any frag-
ment cloned into the pBVboostFG vector should be easily
transferred to any other vector utilizing the same system, and
vice versa (8).
To the best of our knowledge, the current study provides
the ﬁrst example where simple SES-PCR has been used to
generate the long attL sites required for recombinational clon-
ing utilizing the bacteriophage lambda system (8) on the scale
of library construction. This strategy has the beneﬁt that SES-
PCR products can be cloned directly into recombinational
cloning-compatible expression vectors like pBVboostFG.
This makes the method fast and cost-effective. The SES-
PCR strategy ﬁts well for randomization and DNA shufﬂing
of genes as demonstrated in the present study. For high-
throughput setups, however, we would ﬁnd it interesting to
convert the ready-made entry format libraries such as those
described by Pearlberg and LaBaer (5) into pBVboostFG
format. This would be especially useful if such annotated
expression clones already contained fusion tags suitable for
the detection and puriﬁcation of the produced proteins. The
current form of the pBVboostFG does not include an option
for fusion tags since His-tag, for example, can be readily
incorporatedintoPCR-primersandthisstrategyavoidsincorp-
oration of extra amino acids into produced proteins.
In vivo transduction of rat brain choroid plexus with
BVboostFG baculovirus provides an interesting target tissue
in the central nervous system; it is responsible for the produc-
tion and maintenance of cerebrospinal ﬂuid (37). In addition,
its involvement in the pathological processes has been
documented (37). Therefore, it is intriguing to speculate the
possibility of using BVboostFG viruses as a tool to produce
secreted therapeutic compounds in the cerebrospinal ﬂuid or
cure disorders associated with the functions of the choroid
plexus.
It is concluded that the pBVboostFG system is a novel tool
for functional genomics that allows a simple, rapid and sim-
ultaneous analysis of libraries and cloned genes in E.coli,
insect and vertebrate cells as well as directly in in vivo animal
models without time-consuming subcloning steps.
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